11173181

Source:http://linkedlifedata.com/resource/pubmed/id/11173181

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013340, umls-concept:C0036043, umls-concept:C0205195, umls-concept:C0227843, umls-concept:C0282402, umls-concept:C0549178
pubmed:issue	3
pubmed:dateCreated	2001-2-22
pubmed:abstractText	To determine the endometrial safety of oral 17beta-oestradiol combined continuously with dydrogesterone in preventing endometrial proliferation.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7807333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Dydrogesterone, http://linkedlifedata.com/resource/pubmed/chemical/Estradiol
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	0378-5122
pubmed:author	pubmed-author:BergeronCC, pubmed-author:FerenczyAA
pubmed:issnType	Print
pubmed:day	31
pubmed:volume	37
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	191-9
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:11173181-Adult, pubmed-meshheading:11173181-Aged, pubmed-meshheading:11173181-Dose-Response Relationship, Drug, pubmed-meshheading:11173181-Double-Blind Method, pubmed-meshheading:11173181-Drug Administration Schedule, pubmed-meshheading:11173181-Dydrogesterone, pubmed-meshheading:11173181-Endometrium, pubmed-meshheading:11173181-Estradiol, pubmed-meshheading:11173181-Female, pubmed-meshheading:11173181-Hormone Replacement Therapy, pubmed-meshheading:11173181-Humans, pubmed-meshheading:11173181-Middle Aged
pubmed:year	2001
pubmed:articleTitle	Endometrial safety of continuous combined hormone replacement therapy with 17beta-oestradiol (1 or 2 mg) and dydrogesterone.
pubmed:affiliation	Laboratoire Pasteur-Cerba, 95006 Cedex 9, Cergy Pontoise, France.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study